Table 2.
Changes in physiological outcomes over 3- and 6-month intervention
| Variable | C n = 17 |
3M n = 29 |
6M n = 68 |
|||
|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | |
| TM time (min ± SEM) | 6.96 (0.5) | 7.20 (0.6) | 5.38 (0.5) | 7.12 (0.5)*,# | 5.22 (0.3) | 6.85 (0.3)*,# |
| Pulmonary function | ||||||
| FVC (%pred ± SEM) | 103.4 (5.3) | 98.5 (4.9) | 108.5 (3.2) | 109.6 (3.2) | 88.6 (1.8) | 92.8 (2.1)*,#,^ |
| FEV1 (%pred ± SEM) | 92.2 (6.2) | 92.8 (5.7) | 100.9 (4.4) | 104.2 (4.4) | 83.6 (2.1) | 89.2 (1.9)* |
| Muscular endurance | ||||||
| Leg Pr (reps ± SEM) | 20 (13) | 32 (2.7)* | 16 (1.3) | 22 (3.2) | 14 (1.0) | 25 (1.6)* |
| Bench Pr (reps ± SEM) | 12 (9) | 16 (1.9) | 12 (0.9) | 14 (1.1) | 9 (0.6) | 16 (0.8)*,^ |
| Lat PD (reps ± SEM) | 16 (8) | 23 (2.9)* | 15 (1.7) | 20 (2.2)* | 13 (.8) | 21 (1.7)* |
| Sh Pr (reps ± SEM) | 9 (5) | 12 (1.5) | 8 (0.7) | 13 (2.0) | 8 (0.5) | 11 (0.4) |
| Crunches (reps ± SEM) | 29 (17) | 25 (4.1) | 17 (1.1) | 26 (4.5)*,# | 20 (1.2) | 27 (1.9)*,# |
*
P < 0.05 pre versus post
#
P < 0.05 versus control group
^
P < 0.05 versus 3-month group